Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes.

Pilar AscasoAna PalancaSergio Martinez-HervasMaría Jesús SanzJuan F AscasoLaura PiquerasJosé T Real

Published in: International journal of clinical practice (2021)

Increased circulating levels of CXCL10 were associated with DPN in T2D patients, suggesting a role of this chemokine in the DPN. Determination of CXCL10 levels could be used as a marker for the early detection and implementation of therapeutic strategies in order to reverse and prevent the DPN.

Keyphrases

peripheral blood
end stage renal disease
chronic kidney disease
ejection fraction
healthcare
primary care
prognostic factors
high resolution